Clinical trials in L'hospitalet De Llobregat – page 138

3 655 clinical trials in L'hospitalet De Llobregat, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

L'hospitalet De Llobregat at a glance

3 655

clinical trials

Research sites4

Quick filters

3 655 trials in L'hospitalet De Llobregat

Open in trial search

Dementia Alzheimer's type

Not recruiting

A study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia

Registered drug

A study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Florbetapir (18F)
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Sjogren's syndrome

Not recruiting

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dazodalibep
Sponsor:Amgen Inc.

Contact Research Centre

Chronic kidney disease+1

Not recruiting

A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Investigational

A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Investigational

Spain

Participants:18–64 years
Substances:BAY 3401016
Sponsor:Bayer AG

Contact Research Centre

Cardiovascular disorder

Not recruiting

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Type 2 diabetes mellitus+3

Not recruiting

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Cagrilintide
Sponsor:Novo Nordisk A/S

Contact Research Centre

Squamous cell carcinoma of head and neck

Not recruiting

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Registered drugNo placebo

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Dostarlimab
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

Dermatitis acneiform

Not recruiting

A study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy

Investigational

A study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Aprepitant
Sponsor:Hoth Therapeutics Inc.

Contact Research Centre

Anti-neutrophil cytoplasmic antibody positive vasculitis

Not recruiting

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Investigational

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Tarperprumig
Sponsor:Alexion Pharmaceuticals Inc.

Contact Research Centre

Systemic scleroderma

Not recruiting

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Investigational

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Tibulizumab
Sponsor:Zura Bio Inc.

Contact Research Centre

Dermatitis atopic

Not recruiting

A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

Investigational

A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:BFB759
Sponsor:Bluefin Biomedicine Inc.

Contact Research Centre

Cardiac failure

Not recruiting

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Ziltivekimab
Sponsor:Novo Nordisk A/S

Contact Research Centre

Parkinson's disease

Not recruiting

Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations

Registered drugNo placebo

Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Levodopa
Sponsor:Zambon Biotech S.A.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 203 cities in Spain

Clinical research in L'hospitalet De Llobregat

What the registry says about research in the country

01 Infectious Disease Prevention

Innovative research focused on vaccine development targeting multiple infectious diseases, including studies on UTI prevention, yellow fever, and RSV protection in adults.

UTI Vaccine Safety & Efficacy
Yellow Fever Immunization
RSV Protection Studies

These trials aim to enhance vaccine effectiveness and improve public health outcomes through preventive measures.

02 Oncology Research

Comprehensive studies exploring new treatments for various types of advanced cancers, with particular focus on targeted therapies and novel drug combinations.

Colorectal Cancer Treatment
Gastric Cancer Therapies
Pancreatic Cancer Interventions

Advanced clinical research investigating innovative approaches to combat various forms of cancer.

03 Transplant Medicine

Groundbreaking research in kidney transplantation, focusing on preventing rejection and improving post-transplant outcomes.

Antibody-Mediated Rejection
Delayed Graft Function
Novel Immunosuppressive Approaches

Studies aimed at enhancing transplant success rates and patient recovery.

04 Autoimmune Conditions

Clinical investigations into treatments for various autoimmune disorders, including innovative therapies for inflammatory conditions.

Psoriatic Arthritis Treatment
Atopic Dermatitis Management
Myasthenia Gravis Therapy

Focused on developing targeted treatments to improve patient quality of life.

Back to Spain All countries

Clinical trials in L'hospitalet De Llobregat – page 138

3 655 trials in L'hospitalet De Llobregat

Dementia Alzheimer's type

A study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia

Sjogren's syndrome

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

Chronic kidney disease+1

A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Cardiovascular disorder

A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease

Type 2 diabetes mellitus+3

A study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese

Squamous cell carcinoma of head and neck

Testing Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned

Dermatitis acneiform

A study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy

Anti-neutrophil cytoplasmic antibody positive vasculitis

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Systemic scleroderma

A study to test if tibulizumab works and is safe for adults with systemic sclerosis

Dermatitis atopic

A study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis

Cardiac failure

A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

Parkinson's disease

Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations

Filter the trials

Other cities in Spain

Clinical research in L'hospitalet De Llobregat

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Clinical trials in L'hospitalet De Llobregat – page 138

3 655 trials in L'hospitalet De Llobregat

Chronic kidney disease+1

Type 2 diabetes mellitus+3

Other cities in Spain

Related

Clinical research in L'hospitalet De Llobregat

Prefer not to search on your own, or looking for clinical trials for a rare disease?